ASLAN Pharmaceuticals and BioGenetics Co Ltd, a leading South Korean healthcare company, today announced that they have entered into an agreement whereby both parties will collaborate to commercialise varlitinib in all indications in South Korea.
For more information, please refer to the English or Chinese press release.